This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
  • Latest Dividend: 0.15
  • Latest Dividend Yield: 0.47%
  • Dividend Ex-Date: 12/11/14
  • Price Earnings Ratio: 30.5652
  • Price Earnings Comparisons:
    TMO Sector Avg. S&P 500
    30.57 30.60 25.92
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    5.11% 25.51% 186.51%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 4.60 0.21 0.07
    Net Income 8.10 0.24 0.07
    EPS 8.60 0.37 0.11
  • Earnings for TMO:
    EBITDA 2.69B
    REVENUE 13.09B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.94 $1.83 $6.92 $7.74
Number of Analysts 10 7 11 11
High Estimate $1.96 $1.88 $6.95 $8.03
Low Estimate $1.93 $1.74 $6.89 $7.44
Prior Year $1.43 $1.53 $5.42 $6.92
Growth Rate (Year over Year) 35.94% 19.70% 27.62% 11.88%
TMO News

TMO Thermo Fisher Scientific Inc

Analysts Ratings for TMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 11 12
Moderate Buy 1 2 2 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TMO ANALYST REPORT

Brokerage Partners

TMO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs